Want to track ATNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Actinium Pharmaceuticals Inc. (ATNM) Statistics
Valuation metrics
Market Cap 28.39M
Enterprise value -11.69M
Trailing P/E (ttm) -1.23
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 321.38
Price/Book (mrq) 12.5
Enterprise Value/Revenue -129.87
Enterprise Value/EBITDA 0.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 74.39K
Average volume (90 days) 164.13K
Price summary
52-Week low 0.88
52-Week high 1.89
Beta -
50-Day moving average 0.98
200-Day moving average 1.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 11 Aug 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -260.79%
Operating margin -283.47%
Operational effectiveness
Return on assets -0.52%
Return on equity -2.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.66
Current ratio (mrq) 5.89%
Book value per share (mrq) 0.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
